Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of recurrent depression

D J Kupfer1

  • 1Department of Psychiatry, University of Pittsburgh School of Medicine, Pa.

The Journal of Clinical Psychiatry
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.

The American journal of psychiatry·1999
Same author

Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder.

Psychiatry research·1999
Same author

Diagnostic certainty of a voluntary bipolar disorder case registry.

Journal of affective disorders·1999
Same author

Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.

The American journal of psychiatry·1999
Same author

Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication.

Journal of psychiatric research·1999
Same author

Consensus criteria for traumatic grief. A preliminary empirical test.

The British journal of psychiatry : the journal of mental science·1999

Full-dose antidepressant medication, like tricyclic antidepressants (TCAs), effectively prevents recurrent major depression for up to five years. Newer agents are also showing promise for long-term depression management.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Major depression is a chronic, recurrent illness.
  • Current maintenance treatments often use lower antidepressant doses than for acute phases.

Purpose of the Study:

  • To evaluate the efficacy of full-dose tricyclic antidepressant (TCA) maintenance therapy in preventing recurrent depression.
  • To explore alternative long-term management strategies for recurrent depression.

Main Methods:

  • Long-term randomized, double-blind studies were conducted.
  • Tricyclic antidepressant (TCA) maintenance therapy was compared to other treatments.
  • Interpersonal psychotherapy was also assessed.

Main Results:

  • Full-dose TCA maintenance therapy demonstrated a significant prophylactic effect for up to 5 years.

Related Experiment Videos

  • Monthly interpersonal psychotherapy showed a modest but significant effect.
  • Full-dose TCAs were well-tolerated with proper patient education and support.

    • Conclusions:

    • Full-dose TCA maintenance therapy is a highly effective strategy for preventing recurrent depression.
    • Newer antidepressant agents, such as serotonin selective reuptake inhibitors, show potential for long-term prophylaxis due to milder side effect profiles.